Trend Price Analysis of Drug Before and After the Implementation of E-catalogue at the Hospital

https://doi.org/10.22146/jmpf.44496

Yusi Anggriani(1*), Prih Sarnianto(2), Siti Aisyah(3), Jenny Pontoan(4)

(1) Graduate School of Pharmacy, Faculty of Pharmacy, Universitas Pancasila, Jakarta
(2) Graduate School of Pharmacy, Faculty of Pharmacy, Universitas Pancasila, Jakarta
(3) Graduate School of Pharmacy, Faculty of Pharmacy, Universitas Pancasila, Jakarta
(4) Faculty of Pharmacy, Institut Sains dan Teknologi Nasional, Jakarta
(*) Corresponding Author

Abstract


In 2013, Ministry of Health, Republic of Indonesia, launched a new change to drug procurement system, namely e-catalogue, to ensure the availability and affordability of medicines. This system replaces the previous auction drug procurement system. The purpose of the change into e-catalogue system is to facilitate the drug procurement in hospitals without the need to conduct complex negotiation with producers, to reduce the occurrence of mark-ups or inflating drug prices, to equalize drug prices, to support BPJS (Badan Penyelenggara Jaminan Sosial) activities, and to prevent difficulties in drug distribution in all regions in Indonesia. This study aims to get an overview and magnitude of the impact of e-catalogue application on changes in the price of drugs registered and not registered in e-catalogue at Jakarta Islamic Hospital Cempaka Putih. This research is a longitudinal time series study. The data collection was conducted retrospectively in the period of 2011-2015 taken from procurement data, purchase invoices, and e-catalogue prices from hospital pharmacy installation, which were then categorized based on similar drugs in the hospital. The result shows a decrease in the price of drugs on both e-catalogue drugs (generic, trade names and patents) and non e-catalogue drugs (generic, trade names). On the class of therapy, the biggest price reduction occurred in e-catalogue medicine, such as in antineoplastics, intravenous solution, diabetes, Anti-ashma & COPD, and psycholeptics therapy. Meanwhile, on the category of non e-catalogue, price reduction occurred in systemic antibacterials, antineoplastics, analgesics, cardiac theraphy, and A-acis A-flat A Ulcerants therapy. The magnitude of drug prices reduction ranges from 1% to more than 90% both on e-catalogue drugs and non e-catalogue drugs. On the e-catalogue drugs, the highest price reduction (82.36%) occurred in generic and patent drugs, while on non e-catalogue drugs, reduction occurred in drugs with trade names. The price reduction trend in drug prices based on both type of drugs and therapy class shows a significant decrease in drug prices in the period after the implementation of e-catalogue at Jakarta Islamic Hospital in Cempaka Putih, with a decrease of more than 80%.


Keywords


e-catalogue; harga obat; rumah sakit; e-catalogue; drug price; hospital

Full Text:

PDF


References

1. Rock C. Indonesia Health Sector Review : Policy Note Series. Policy Note Pharm. 2009;(March):1–11.

2. Handayani R, Supardi S, Raharni, Susyanty A. Ketersediaan dan Peresepan Obat Generik dan Obat Esensial di Fasilitas Pelayanan Kefarmasian di 10 Kabupaten/Kota di Indonesia. Bul Penelit Sist Kesehat. 2010;Vol.13 No.:54–60.

3. Simoens S. A Review of Generic Medicine Pricing in Europe. Generics Biosimilars Initiat J. 2012;1(1):8–12.

4. Brandt L. Price Tagging the Priceless : International Reference Pricing for Medicines in Theory and Practice. Ecipe Policy Briefs. 2013;No.03(4).

5. Anggriani Y, Ibrahim MIM, Sri S, Shafie AA. The Impact of Indonesian Generic Medicine Pricing Policy on Medicine Prices. J Generic Med. 2013;Vol.10(3–4):219–29.

6. Kusmini, Satibi, Suryawati S. Evaluasi Pelaksanaan E-Purchasing Obat Pada Dinas Kesehatan Kabupaten / Kota Di Jawa Tengah Tahun 2015 Evaluation of Medicines E-Purchasing At District Health Offices / Municipalities in Central Java Province 2015. J Manaj dan Pelayanan Farm. 2016;6:277–87.

7. Ningsih A, Fudholi A, Sumarni. Relationship of Application Catalogue Electronic Toward Efficiency. J Manaj dan Pelayanan Farm. 2015;Vol.5 No.4:241–8.

8. Sari AP. Evaluasi Pemanfaatan Sistem e-Catalogue Terhadap Efektifitas dan Efisiensi Pengadaan Obat di Instalasi Farmasi (Studi di Wilayah Gerbangkertasusila). Universitas Airlangga Surabaya; 2016.

9. Oktaviani A, Baroroh F. Studi Pengelolaan Obat Sebelum dan Sesudah JKN di Puskesmas Jetis Kota Yogyakarta. J Ilm Kefarmaian. 2015;Vol 5 No.1:85–92. From: http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/2290/1457

10. Anggriani Y, Purwanggana A, Restinia M. Clinical Outcomes Among Type 2 Diabetes Mellitus Patients: Before and After Universal Health Coverage in Indonesia. Asian J Pharm Clin Res [Internet]. 2017;10(5):156.

11. Restinia M, Anggriani Y, Kusumaeni TRI, Meryta A. Profil Pengobatan Pasien Rawat Jalan Diabetes Melitus Tipe 2 setelah Pelaksanaan JKN. J Ilmu Kefarmasian Indones. 2015;13(April):63–8.

12. Dewi DAPS, Satibi S, Puspandari DA. Analisis Biaya Obat Pada Era JKN Dan Faktor-Faktor Yang Mempengaruhi Di Fasilitas Penunjang Kesehatan Daerah Istimewa Yogyakarta. J Manag Pharm Pract [Internet]. 2015;5(4):283–91.

13. Lembaga Kebijakan Pengadaan Barang/Jasa Pemerintah R. Peraturan Kepala Lembaga Kebijakan Pengadaan Barang Jasa Pemerintah Nomor I Tahun 2015 tentang E-Tendering. 2015.

14. Teo TSH, Ranganathan C. Adopters and Non-Adopters of Business-to-Business Electronic Commerce in Singapore. Inf Manag. 2004;42:89–102.

15. Maulidie M, Saputera A. Perencanaan di Era Jaminan Kesehatan Nasional di RSUD H. Hasan Basery Kandangan Tahun 2014. J Ilm Ibnu Sina. 2014;1(September 2016):248–55.

16. Siahaan S, Handayani RS, Sari ID, Fitri N. Medicines Prices and Availability in Primary Health Cares , Hospitals and Retail Pharmacies in DKI Jakarta. Bul Penelit Sist Kesehat. 2015;Vol.18 No.:29–35.

17. Pujawati H. Analisis Sistem Pengadaan Obat dengan Metode ABC Indeks Kritis (Studi Kasus Pengadaan Obat Jaminan Kesehatan Nasional di Rumah Sakit Panti Rapih Yogyakarta). Tesis. 2015;

18. Michael Rubino, James M. Hoffman, Koesterer LJ, Swendrzynski RG. ASHP Guidelines on Medication Cost Management Strategies for Hospitals and Health Systems Trends in Medication Expenditures. Am J Heal Pharm [Internet]. 2008;Vol. 65, N:1368–84.

19. Darling M, Wise S. Not your father’s Supply Chain. Following Best Practices to Manage Inventory Can Help You Save Big. Mater Manag Health Care [Internet]. 2010;19(4):30–3.

20. Susanto A, Kristin E, Agastya. Identifikasi Faktor yang Mempengaruhi Total Biaya Inventori Obat-Obatan Golongan A di Rumah Sakit Swasta Tipe B di Jakarta Tahun 2015. J Medicoeticolegal dan Manaj Rumah Sakit. 2017;Vol.6 No.1:108.

21. Dwiaji A, Sarnianto P, Thabrany H, Muhammad S. Evaluasi Pengadaan Obat Publik pada JKN berdasarkan Data e-Catalogue Tahun 2014-2015. J Ekon Kesehat Indones. 2016;Vol.1 No.1:39–53.

22. Moon S, Jambert E, Childs M, von Schoen-Angerer T. A Win-win Solution?: A Critical Analysis of Tiered Pricing to Improve Access to Medicines in Developing Countries. Global Health. 2011;7:1–11.

23. Puig-Junoy J. Impact of European Pharmaceutical PricenRegulation on Generic Price Competition A Review. Pharmacoeconomics. 2010;28(8):649–63.

24. Sunarjo AC. Pharmaindo Easy Read- Indonesia ’ s Pharmaceutical Industry. Harga Obat-Obatan Bermerek Turun. Kompas. 2018;1–12.

25. Mendrofa DE, Suryawati C. Analisis Pengelolaan Obat Pasien BPJS di Instalasi Farmasi Rumah Sakit Panti Wilasa Citarum Semarang. J Manaj Kesehat Indones [Internet]. 2016;4(3):214–21. Available from: https://ejournal.undip.ac.id/index.php/jmki/article/view/13757

26. Kementerian Kesehatan RI. Laporan Akuntabilitas Kinerja Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan Tahun 2013. 2014.

27. Biro Komunikasi dan Pelayanan Masyarakat KKR. Perubahan Konsep Pelyanan Rumah Sakit di Era JKN [Internet]. Http://Www.Depkes.Go.Id. Seminar Nasional Perumahsakitan, Surabaya Hospital Expo Shangrila, 7 Mei 2014; 2017. Available from: http://www.depkes.go.id/article/view/17100300004/tahun-ini-150-kabupaten-kota-laksanakan-pemberian-obat-cegah-kaki-gajah-massal.html

28. Siahaan S. Analysis of Prescribing Pattern and the Availability of Medicines at General Hospitals in Indonesia. Bul Penelit Sist Kesehat. 2013;Vol.16(No.4):373–9.

29. Nurkusuma DD. Faktor yang Berpengaruh terhadap Kejadian Methicillin-Resistant Staphylococcus aureus (MRSA) pada Kasus Infeksi Luka Pasca Operasi di Ruang Perawatan Bedah Rumah Sakit Dokter Kariadi Semarang. Universitas Diponegoro Semarang; 2009.

30. Shaban R, Cruickshank M, Christiansen K, Antimicrobial Resistance Standing Committee. National Surveillance and Reporting of Antimicrobial Resistance and Antibiotic Usage for Human Health in Australia. [Internet]. 2013. Available from: http://creativecommons.org/licenses/by/3.0/au/deed.en.%5Cnhttp://creativecommons.org/licenses/by/3.0/au/legalcode.

31. Atmadinata DA, Nasution I, Novitasari A. Studi Deskriptif Pemakaian Antibiotik di Rumah Sakit Roemani Periode Januari 2011 sampai Juni 2011 di Instalasi Penyakit Dalam Bangsal Khodijah. J Kedokt Muhammadiyah. 2012;1(2):1–6.

32. Abdolshah M. A Review of Quality Criteria Supporting Supplier Selection. J Qual Reliab Eng. 2013;2013.

33. Enyinda CI, Emeka D, Bell-Hanyes J. A Model for Quantifying Strategic Supplier Selection : Evidence From a Generic Pharmaceutical Firm Supply Chain. Int J Business, Mark Decis Sci. 2010;3(2):25–44.

34. Dias V. MDS-3: Managing Access to Medicines and Health Technologies. Management Sciences for Health. 2012.

35. Bogaert P, Bochenek T, Prokop A, Pilc A. A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives. PLoS One. 2015;10(5):1–20.

36. Ball D. Pharmaceutical Pricing Policies and Intervention. Working Paper 3: The Regulation of Mark-up in the Pharmaceutical Supply Chain. WHO / HAI Proj Med Prices Availab [Internet]. 2011;Working Pa:66. Available from: http://www.haiweb.org/medicineprices/24072012/CompetitionFinalMay2011.pdf

37. Sood N, Vries H De, Gutierrez I, Lakdawalla D, Goldman D. The Effect of Regulation on Pharmaceutical Revenues: Experience in Nineteen Countries. Heal Aff. 2009;28(1):1–24.



DOI: https://doi.org/10.22146/jmpf.44496

Article Metrics

Abstract views : 943 | views : 535

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This Journal is Indexed on:


Web
Analytics View My Stats